Skip to content
Instagram Facebook-f Twitter Youtube
  • About
  • Blog
  • Issues
    • Antitrust
    • Congress
    • Defense
    • Earmarks
    • Energy
    • Federal Agencies
    • Harm Reduction
    • Healthcare
    • Intellectual Property
    • International Issues
    • Postal Reform
    • Regulation
    • Spending
    • State Issues
    • Taxes
    • Technology
    • Telecommunications
  • Newsroom
  • Publications
  • Contribute
  • Consumer Center
  • About
  • Blog
  • Issues
    • Antitrust
    • Congress
    • Defense
    • Earmarks
    • Energy
    • Federal Agencies
    • Harm Reduction
    • Healthcare
    • Intellectual Property
    • International Issues
    • Postal Reform
    • Regulation
    • Spending
    • State Issues
    • Taxes
    • Technology
    • Telecommunications
  • Newsroom
  • Publications
  • Contribute
  • Consumer Center

Menu

Blog

Issues

  • Congress
  • Defense
  • Earmarks
  • Energy
  • Federal Agencies
  • Healthcare
  • Harm Reduction
  • Intellectual Property
  • International Issues
  • Postal Reform
  • Regulation
  • Spending
  • State Issues
  • Taxes
  • Telecommunications
  • Technology
  • Congress
  • Defense
  • Earmarks
  • Energy
  • Federal Agencies
  • Healthcare
  • Harm Reduction
  • Intellectual Property
  • International Issues
  • Postal Reform
  • Regulation
  • Spending
  • State Issues
  • Taxes
  • Telecommunications
  • Technology

Category: Food and Drug Administration

Makary Must Go

Read More »
May 8, 2026 No Comments

FDA Takes a Step Toward Harm Reduction but Still Has Work to Do

Read More »
May 7, 2026 No Comments

Bring Smokeless Tobacco Sticks to America

Read More »
April 24, 2026 No Comments

HHS Budget Hearings Offer Rare Opportunity to Reform FDA

Read More »
April 21, 2026 No Comments

Consumer Watchdog Praises IQOS Reauthorization, Urges Broader Support for Smoking Alternatives

Read More »
April 20, 2026 No Comments

Watchdog Warns Against New Drug Tariffs

Read More »
April 3, 2026 No Comments

The First-Year Checkup: RFK Jr.’s Policies on the Pain Scale

Read More »
April 2, 2026 No Comments

New TPA Report Finds FDA Costs Soaring, Drug Rejections Rising

Read More »
March 26, 2026 No Comments

New TPA Report Finds FDA Costs Soaring, Drug Rejections Rising

Read More »
March 26, 2026 No Comments

Post-Prasad, FDA Must Embrace Reform

Read More »
March 24, 2026 No Comments
Page1 Page2 Page3 … Page12

Copyright © 2026 Taxpayers Protection Alliance

1101 14th Street NW, Suite 500 Washington, D.C. 20005

Privacy Policy           Press Inquiries